PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $2,620,000 | +29.8% | 270,700 | +11.4% | 0.01% | -13.3% |
Q1 2014 | $2,018,000 | +3.6% | 242,900 | +5.2% | 0.02% | -6.2% |
Q4 2013 | $1,948,000 | -29.5% | 230,800 | -34.5% | 0.02% | +6.7% |
Q3 2013 | $2,763,000 | +104.8% | 352,100 | +101.5% | 0.02% | 0.0% |
Q2 2013 | $1,349,000 | – | 174,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |